17 Jun Prostate Cancer News – PRX302 (topsalysin) may help men avoid radical treatment
This new trial is very exciting” for localised prostate cancer. PRX302 (topsalysin).
Read what Prof Mark Emberton has to say about this new trial.
The research leader Dr Hashim Ahmed says that this treatment could help some men avaoid radicl surgery or radiation therapy.